Arnaud Bonnefoy

2.2k total citations
58 papers, 1.6k citations indexed

About

Arnaud Bonnefoy is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Arnaud Bonnefoy has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 15 papers in Genetics and 13 papers in Molecular Biology. Recurrent topics in Arnaud Bonnefoy's work include Platelet Disorders and Treatments (28 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Complement system in diseases (11 papers). Arnaud Bonnefoy is often cited by papers focused on Platelet Disorders and Treatments (28 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers) and Complement system in diseases (11 papers). Arnaud Bonnefoy collaborates with scholars based in Canada, France and Belgium. Arnaud Bonnefoy's co-authors include Marc Hoylaerts, Chantal Legrand, Jos Vermylen, Petra Vandervoort, Rita De Vos, Kim Daenens, Mony M. Frojmovic, Georges‐Étienne Rivard, Hendrik B. Feys and Pascal Maurice and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Arnaud Bonnefoy

57 papers receiving 1.5k citations

Peers

Countries citing papers authored by Arnaud Bonnefoy

Since Specialization

Citations

This map shows the geographic impact of Arnaud Bonnefoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Bonnefoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Bonnefoy more than expected).

Fields of papers citing papers by Arnaud Bonnefoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Bonnefoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Bonnefoy. The network helps show where Arnaud Bonnefoy may publish in the future.

Co-authorship network of co-authors of Arnaud Bonnefoy

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Bonnefoy. A scholar is included among the top collaborators of Arnaud Bonnefoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Bonnefoy. Arnaud Bonnefoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Significance of Immune Deposits and Complement System Activation in FSGS 2025 ·Kidney360 ·Yaşar Çalışkan, Virginie Royal, Stéphan Troyanov, Arnaud Bonnefoy, Clémence Merlen, Mark A. Schnitzler, John C. Edwards, Krista L. Lentine, (unknown)	0
2	Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis 2022 ·Kidney International Reports ·Dominique S. Genest, Arnaud Bonnefoy, (unknown), Clémence Merlen, Geneviève Genest, Anne‐Laure Lapeyraque, Natacha Patey, (unknown), Virginie Royal, Stéphan Troyanov	14
3	Predictive significance of anti‐FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: Results from the Quebec Reference Center for Inhibitors 2021 ·Journal of Thrombosis and Haemostasis ·Arnaud Bonnefoy, Clémence Merlen, Évemie Dubé, (unknown), Georges‐Étienne Rivard, Jean St‐Louis	7
4	Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants 2020 ·Frontiers in Medicine ·François Marceau, Georges E. Rivard, Julie Gauthier, Karen Binkley, Arnaud Bonnefoy, Isabelle Boccon‐Gibod, Laurence Bouillet, Matthieu Picard, (unknown), (unknown), Hélène Bachelard, Jacques Hébert, Konrad Bork	18
5	Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy 2019 ·Kidney International Reports ·(unknown), Arnaud Bonnefoy, Hugo Chapdelaine, Vincent Pichette, (unknown), François Madore, Soumeya Brachemi, Stéphan Troyanov	22
6	Effect of ABO blood group on haemostatic parameters in severe haemophilia A patients performing acute moderate-intensity exercise 2018 ·Blood Coagulation & Fibrinolysis ·Clémence Merlen, N. Zourikian, Arnaud Bonnefoy, Évemie Dubé, (unknown), Jean St‐Louis, Georges‐Étienne Rivard	1
7	Transcriptomic landscape of acute promyelocytic leukemia reveals aberrant surface expression of the platelet aggregation agonist Podoplanin 2018 ·Leukemia ·Vincent‐Philippe Lavallée, Jalila Chagraoui, Tara MacRae, Miriam Marquis, Arnaud Bonnefoy, Jana Krošl, Sébastien Lemieux, Anne Marinier, Caroline Pabst, Georges‐Étienne Rivard, Josée Hébert, Guy Sauvageau	32
8	Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial 2012 ·American Heart Journal ·Catherine Martel, Christopher B. Granger, (unknown), Amanda Stebbins, Annik Fortier, Paul W. Armstrong, Arnaud Bonnefoy, Pierre Théroux	32
9	Effects of P2Y₁receptor antagonism on the reactivity of platelets from patients with stable coronary artery disease using aspirin and clopidogrel 2011 ·British Journal of Pharmacology ·(unknown), (unknown), Marijke Bryckaert, Pierre Théroux, Arnaud Bonnefoy	6
10	Angiopoietin-1 but not angiopoietin-2 promotes neutrophil viability: Role of interleukin-8 and platelet-activating factor 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown), Catherine Martel, Paul‐Eduard Neagoe, Arnaud Bonnefoy, Martin G. Sirois	15
11	Requirements for Membrane Attack Complex Formation and Anaphylatoxins Binding to Collagen-Activated Platelets 2011 ·PLoS ONE ·Catherine Martel, Sylvie Cointe, Pascal Maurice, (unknown), (unknown), Pierre Théroux, Arnaud Bonnefoy	57
12	Nuclear-delimited Angiotensin Receptor-mediated Signaling Regulates Cardiomyocyte Gene Expression 2010 ·Journal of Biological Chemistry ·Artavazd Tadevosyan, Ange Maguy, Louis Villeneuve, (unknown), Arnaud Bonnefoy, Bruce G. Allen, Stanley Nattel	95
13	Involvement of the Mitogen-activated Protein Kinase c-Jun NH2-terminal Kinase 1 in Thrombus Formation 2007 ·Journal of Biological Chemistry ·Alexandre Kauskot, Frédéric Adam, Alexandra Mazharian, Nadine Ajzenberg, Eliane Berrou, Arnaud Bonnefoy, Jean‐Philippe Rosa, Marc Hoylaerts, Marijke Bryckaert	39
14	Type III collagen mimetic peptides designed with anti- or pro-aggregant activities on human platelets 2007 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Sophie Da Nascimento, Pascal Maurice, Arnaud Bonnefoy, Alexandra Dassonville‐Klimpt, Carole Amant, Françoise Fauvel-Lafève, Chantal Legrand, Jacques Rochette, Pascal Sonnet	7
15	L'imagerie par bioluminescence pour visualiser la progression tumorale et la métastase chez le petit animal 2007 ·Journal de la Société de Biologie ·Alexandre Kauskot, Jan Manent, Fabrice Chareyre, Márcia R. Cominetti, Martine Chopin, Marco Giovannini, Chantal Legrand, Arnaud Bonnefoy	3
16	von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen 2006 ·Journal of Thrombosis and Haemostasis ·Arnaud Bonnefoy, Roland A. Romijn, Petra Vandervoort, (unknown), J. Vermylen, Marc Hoylaerts	51
17	Differential Involvement of ERK2 and p38 in Platelet Adhesion to Collagen 2005 ·Journal of Biological Chemistry ·Alexandra Mazharian, (unknown), Pascal Maurice, Eliane Berrou, Michel R. Popoff, Marc Hoylaerts, Françoise Fauvel-Lafève, Arnaud Bonnefoy, Marijke Bryckaert	53
18	αIIbβ3antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium 2004 ·Journal of Thrombosis and Haemostasis ·Els Melis, Arnaud Bonnefoy, Kim Daenens, Hiroshi Yamamoto, J. Vermylen, Marc Hoylaerts	15
19	Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis 2003 ·Expert Review of Cardiovascular Therapy ·Arnaud Bonnefoy, Jos Vermylen, Marc Hoylaerts	19
20	Rational Optimization of a Short Human P-selectin-binding Peptide Leads to Nanomolar Affinity Antagonists 2003 ·Journal of Biological Chemistry ·Chantal C.M. Appeldoorn, Tom J.M. Molenaar, Arnaud Bonnefoy, Steven H. van Leeuwen, Petra Vandervoort, Marc Hoylaerts, Theo J.C. van Berkel, Erik A.L. Biessen	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact